Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Endologix names new vice president of quality
Mr Sorsher brings 20 years of quality assurance experience, including the past 15 years in medical devices with Bard Peripheral Vascular and Cordis, a Johnson & Johnson. Most
Mr Sorsher brings 20 years of quality assurance experience, including the past 15 years in medical devices with Bard Peripheral Vascular and Cordis, a Johnson & Johnson. Most
By taking this action, MethylGene, after a 90-day transition period, will no longer be responsible for funding development costs required to obtain market approval for MGCD0103, and Celgene
This new tool enables scientists to leverage the power of computer-aided virtual drug screening technology for novel cancer drug discovery and development and will accelerate the speed of
Mr Cornelison comes to Cardiac Dimensions from Arrow International, a medical device company that manufactures critical care and cardiac assist devices. While there, he held numerous senior management
Scientific activities of the partnership will be conducted in facilities of both St Joseph’s Hospital and Medical Center and InNexus’s GLP (Good Lab Practice) certified drug development laboratories
The Scient’x Tribeca cage implants are indicated for use with autogenous bone graft as an intervertebral body fusion device at either one or two contiguous levels in the
The autocontouring technology automatically identifies and draws the boundaries of the prostate and surrounding critical structures, enabling the treatment planning software to focus radiation dose on the prostate
According to the company, Matrix RF utilizes Syneron’s fractional radio frequency technology to provide fractional tissue heating at three ablation and coagulation relative ratios, resulting in effective wrinkle
Mr O’Connor will serve as a class III director, standing for election at the next annual meeting of the company’s shareholders, and will also serve as chairman of
Ms Ahlberg will terminate her employment at Vitrolife in January 2009. The work of recruiting her successor is ongoing. Ms Ahlberg will begin to work at Global Health